Abstract
Introduction 29
Pain is the most prominent and disabling symptom of osteoarthritis (OA) . 30 Symptom-modifying therapy is the only available treatment for knee OA; therefore, it is 31 important to understand the factors causing the pain in order to optimally treat this common 32 disease. The pain in knee OA is a type of nociceptive pain 1 . It has been speculated that 33 detrimental mechanical loading across the joint and inflammation, especially synovitis, may be 34 the main factors associated with the severity of pain 1, 2 . 35 Detrimental mechanical loading across the knee joint is speculated to be one of the main 36 factors in the pathophysiology of knee OA. The alignment of the lower limb has been reported 37 to associate with pain in knee OA 3 . The malalignment of the lower limb and excess body mass 38 have both been considered to be risk factors for the progression of knee OA, due to the 39 association between these factors and the joint load [4] [5] [6] [7] [8] . 40 pg. 8 prescribed by physicians in the previous three months, (2) those who had RA or arthritis due to 86 infection or injury, (3) patients who had undergone joint replacement surgery, (4) patients who 87 had secondary knee OA, (5) patients with patello-femoral OA with a K/L grade of 3 or higher 88
and (6) patients with severe OA (K/L grade 3 or higher) in their hip joint. 89 
90

Radiographic evaluation of the stage of progression and alignment of the lower extremity 91
The staging of knee OA on radiograph was assessed using the K/L grade (scale 1-4) 21 . 92 All radiographs were taken by experienced technicians and were quantified by two readers who The alignment angle was measured by the method reported previously [24] [25] [26] . The femoral 100 anatomic axis was found by drawing a line from the center of the tibial spines to a point 10 cm 101 above the tibial spines, midway between the medial and lateral femoral surfaces. For the tibial 102 anatomic axis, a line was drawn from the center of the tibial spines to a point 10 cm below thepg. 9 tibial spines, midway between the medial and lateral tibial surfaces. The internal angles between 104 the femoral and tibial axes were measured using a computer and the angle was designated as the 105 alignment angle (anatomical alignment angle, AAA). In this method, AAA under 180 indicates 106 varus knee alignment. 107
108
Knee OA pain 109 Pain was evaluated by a visual analogue scale (VAS, 0-100) and the Japanese Knee 110
Osteoarthritis Measure (JKOM) score 27 . The JKOM is a patient-based, self-answered evaluation 111 score that includes four subcategories: pain and stiffness (JKOM-pain; total of eight questions, 112 0-32 points), activities of daily living (ADL) score (total of ten questions, 0-40 points), 113 participation in social activities score (total of five questions, 0-20 points), and general health 114 conditions (total of two questions, 0-8 points) with 100 points as the maximum score. The 115 JKOM score is higher in patients with more pain and physical disability, and this evaluation 116 modality is considered to have sufficient reliability and validity for studies of the clinical 117 outcomes of Japanese subjects with knee OA. The measure has also been shown to have previous study 27 . We assessed the pain severity using both the pain VAS score and JKOM-pain 122 scores in this study. 123
124
Serum IL-6 and hs-CRP levels 125 Serum samples were obtained from all patients on the day that pain and function were 126 assessed, and radiographs were taken. The non-fasting morning blood samples were collected 127 from 9 to 11 in the morning at the outpatient clinic. The serum samples were stored at -80ºC 128 until they were analyzed. A chemiluminescent enzyme immunoassay was used for the 129 measurement of the serum IL-6 concentration (minimum 0.2 pg/mL; reagent: human IL-6; 130 cartridge and instrumentation: Lumipluse Forte; Fujirebio, Tokyo, Japan: intra-assay and 131 interassay variations less than 5.2% and 6.5%, respectively). The serum CRP concentration was 132 measured by latex agglutination nephelometry (reagent: CardioPhase hs-CRP; instrumentation: 133 BN Pro Spec; Siemens Healthcare Diagnostics Inc., NY, USA: intra-assay and interassay 134 variations less than 2% and 3.5%, respectively). 135
136
Statistical analysis 137
Descriptive statistics of age, BMI, IL-6, hs-CRP and AAA were calculated [mean, standard 138 deviation (SD)]. The independent t-test was used to compare mean variables between early andpg. 11 advanced group. To examine the associations between biomarkers, alignment and knee pain 140 scores, β-coefficient was estimated after adjusting for age and the BMI using a multiple linear 141 regression analysis. A p-value < 0.05 was considered to be statistically. All statistical analyses 142 were performed using the SPSS15.0J software program (SPSS, Chicago, IL, USA). 2011 were initially enrolled , 22 patients (10.9%) were excluded since they did not meet the 148 study criteria, the remaining one-hundred eighty patients were included in the data analysis. 149
Among these 180 patients, as 20 patients (11.1%) were excluded due to invalid clinical 150 evaluation scores or incomplete hematological data, so the remaining 160 patients (88.9%) were 151 included in the analysis. 152 The patient characteristics are shown in Table 1 . The radiographic OA severities of the 153 patients were 67 (41.9%) with a K/L grade of 2, 51 (31.9%) with a K/L grade of 3, and 42 154 (26.2%) with a K/L grade of 4. While no significant differences in the age of the patients were 155 observed between the early-(K/L grade 2) and advanced-stage (K/L grades 3 and 4) knee OA 156 group, the BMI of the patients with an advanced-stage knee OA was significantly higher in 157 comparison to that of those with an early-stage knee OA. No significant differences in the pain 158 VAS score, the JKOM-pain score, serum IL-6 and hs-CRP levels were observed between the 159 patients with early-stage and advanced-stage knee OA. On the other hand, the AAA of the 160 patients with an advanced-stage knee OA was significantly smaller in comparison to that of thepg. 13 patients with an early-stage knee OA. 162
163
Factors associated with the pain severity in patients with knee OA 164 A multiple linear regression analysis indicated that the serum IL-6 levels and the AAA 165 both associated with the pain severity, as evaluated by the pain VAS score in the patients when 166 whole patients were included in the analysis (Ta ble 2). On the other hand, the serum levels of 167 IL-6 were solely associated with the pain VAS score in the patients with early-stage knee OA, 168 while the AAA was solely associated with the pain VAS score in the patients with 169 advanced-stage knee OA. 170 Similarly, when the JKOM-pain score was used to evaluate the pain severity, the serum 171 IL-6 levels and the AAA were both associated with the pain severity in the whole patients 172 (Table 3 ). In addition, the serum levels of IL-6 and the AAA solely associated with the 173 confirming that there were differences in the pain-associated factors according to the stage of 175 the disease.
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Discussion 177
The present study has revealed, for the first time, that the factors associated with the 178 pain severity in patients with knee OA varied with the radiographic disease severity. IL-6, which 179 is related to synovitis, was mainly associated with the pain severity in early-stage knee OA, 180 while the AAA was mainly associated with that in the advanced-stage knee OA. be related to the results of these previous studies. 195 Although the serum hs-CRP, as well as IL-6, levels became high according to the 196 progression of OA, in patients with early stage, the levels of IL-6, but not those of hs-CRP, 197 significantly associated with the pain severity. The reason for the difference in this association is 198 not clear. Circulating IL-6 is known to stimulate CRP production by the liver. CRP is a 199 component of circulating serum β-globulin which is produced in the liver reacts to systemic and 200 local tissue damage. IL-6 is a cytokine which is produced at a local site where cellular or tissue 201 damage occurs. In addition, IL-6 is also produced by adipose tissue, which accompanies 202 obesity 34 . As BMI of the patients with advanced-stage knee OA was significantly increased in 203 comparison to that of those with early-stage knee OA in the present study (Table 1) , serum IL-6 204 levels may be affected by the IL-6 produced by adipose tissues, in addition to a local site in the 205 knee joint. Therefore, further study using synovial fluid, which is one of the sources to observe 206 the local joint event, is necessary to clarify this question. 207 The mechanical loading across the knee joint, which was estimated by the knee 208 adduction moment (KAM), was speculated to be higher due to the deteriorating lower limb 209 alignment, and also because of increasing body weight 7 . However, it had not been elucidated to 210 what extent the mechanical loading across the knee joint contributes to the knee joint pain in 211 patients with knee OA. There was a weak correlation between the pain severity and either the 1, 2 and 3) . In the patients with advanced-stage knee OA, an association was 220 identified between pain severity and the KAM, while no association was observed in the 221 patients with early-stage knee OA 35 . Among the early-stage with knee OA (K/L grade 2), the 222 KAM significantly increased in patients with knee pain compared to those without pain 36 . 223 Simultaneously, the alignment of lower limb in the patients with knee pain also significantly 224 increased (more varus lower limb alignment) in comparison to that in those without knee pain 36 . 225 Although, it is still remains unclear precisely how joint loading induces pain in patients with 226 knee OA and such joint loading was not measured in the present study, the results of the present 227 study suggest that the pain in the advanced-stage of knee OA is associated with the mechanical 228 loading across the knee joint, which is associated with a deterioration of the lower limb 229 alignment 35 .
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The current study was associated with some limitations. First, the present study is 231 cross-sectional. The study deals with changes of the disease pathology according to the 232 progression. Progression is time-related and ideally, the study should be designed longitudinally. 233 In this context, the results obtained in this study may be understood as an indirect evidence. 234 Secondly, the patients were divided into two subgroups for statistical analysis. The number of 235 patients with advanced-stage OA was more by about fifty percent than that with early-stage OA. 236 This may have produced the possibility of generating statistical bias comparing the two 237 subgroups. Thirdly, the serum IL-6 levels have been reported to show a circadian rhythm 37 , the 238 serum sample collection was not timed but collected in the morning and the patients had not 239 fasted. While it was not examined whether the serum IL-6 levels show diurnal and 240 activity-related variations, some biomarkers have been reported to have such variations [38] [39] [40] . 241 Further studies are required to clarify whether there are time of day-and activity-related 242 variations in the expression of IL-6 and hs-CRP 38 . Because we did not conduct detailed 243 phenotyping of other joints, the contribution of other joints to the systemic levels of biomarkers 244 cannot be addressed. 245
In conclusion, the presence of a higher level of sIL-6 is thus considered to be 246 associated with pain in early-stage knee OA, while the varus alignment of the joint was found to 247 be associated with pain in advance-stage knee OA patients. 
